Últimas Noticias

CGHE is announcing champions for 2023: Dr. Javier Crespo’s Nomination

This week, CGHE is announcing their champions for 2023, recognizing the remarkable contributions of individuals to improved political commitment, policies, and programs that expand access to interventions and accelerate progress toward hepatitis elimination, particularly with limited resources.

International Symposium on Rare Liver Diseases 2024

The International Symposium on Rare Liver Diseases 2024 promises to be a landmark event for medical professionals and researchers dedicated to advancing knowledge in the field of liver diseases. Scheduled for April 11 and 12, 2024, at the Centro Botín in Santander, Spain.

Es incuestionable que el Fibroscan tiene limitaciones, sobre todo en pacientes con obesidad. En estos casos, el Fibroscan esplénico y otros biomarcadores pueden ser especialmente útiles y ...disminuir la zona de incertidumbre.

https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00234-6/abstract

🏥 Entrevista con Ana Isabel de Santiago, la Jefa de Psiquiatría de Valdecilla: «Lo primero es pedir ayuda al entorno más cercano y, después, a los sistemas sanitarios»

✏️Every day you can learn.
🕯️Breakthrough in #MASLD research! 🧬 Genetic ties between renin-independent aldosteronism and liver disease revealed. Could targeting aldosterone receptors be ...the next big therapy?
@AEEHLiver @sepdigestiva @EASLnews @AASLDtweets
https://www.sciencedirect.com/science/article/pii/S0261561424004527

In CTP B and C cirrhosis patients with high-risk varices, combination of carvedilol and VBL is more effective than either therapy alone, for primary prevention of variceal bleeding.
@EASLnews ...@AEEHLiver @sepdigestiva @AASLDtweets

Instituciones

Patrocinadores